Qifeng Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Surgery 72
- Esophageal Cancer Research and Treatment 58
-
- Lung Cancer Diagnosis and Treatment 13
- Lung Cancer Treatments and Mutations 11
- Gastric Cancer Management and Outcomes 10
- Co-authors
- Xianghuo He (20 shared papers)Shenglin Huang (13 shared papers)Linhui Liang (9 shared papers)Ming Yao (11 shared papers)Jinjun Li (10 shared papers)Taoyang Chen (8 shared papers)Xiang Du (8 shared papers)Yingjun Zhao (5 shared papers)
- Journals
- Frontiers in Oncology (13 papers)BMC Cancer (8 papers)Radiation Oncology (7 papers)Cancer Medicine (6 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qifeng Wang
159 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 128
- Cancer Research 1.3k
- Oncology 561
- Molecular Biology 1.5k
- Pulmonary and Respiratory Medicine 389
- Surgery 512
Countries citing papers authored by Qifeng Wang
This map shows the geographic impact of Qifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Wang more than expected).
Fields of papers citing papers by Qifeng Wang
This network shows the impact of papers produced by Qifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Wang. The network helps show where Qifeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qifeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 229 | |
| 2 | 2012 | 199 | |
| 3 | 2015 | 195 | |
| 4 | 2011 | 115 | |
| 5 | 2013 | 115 | |
| 6 | 2015 | 100 | |
| 7 | 2014 | 86 | |
| 8 | 2015 | 78 | |
| 9 | 2013 | 72 | |
| 10 | 2020 | 72 | |
| 11 | 2015 | 72 | |
| 12 | 2014 | 68 | |
| 13 | 2014 | 66 | |
| 14 | 2014 | 63 | |
| 15 | 2015 | 62 | |
| 16 | 2013 | 60 | |
| 17 | 2012 | 49 | |
| 18 | 2013 | 47 | |
| 19 | 2014 | 41 | |
| 20 | 2009 | 40 |
About Qifeng Wang
Qifeng Wang is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 170 papers that have together received 3.2k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (58 papers), Lung Cancer Diagnosis and Treatment (13 papers), MicroRNA in disease regulation (11 papers), Lung Cancer Treatments and Mutations (11 papers), Cancer Diagnosis and Treatment (10 papers), Gastric Cancer Management and Outcomes (10 papers), RNA modifications and cancer (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (561 citations), Molecular Biology (1.5k citations), Pulmonary and Respiratory Medicine (389 citations) and Surgery (512 citations). Qifeng Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xianghuo He, Shenglin Huang, Linhui Liang, Ming Yao, Jinjun Li, Taoyang Chen, Xiang Du, Yingjun Zhao, Weiqi Sheng and Weijie Guo. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Radiation Oncology, Cancer Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.